ARS Pharmaceuticals, Inc. (SPRY)
3.69
+0.04
(+1.10%)
USD |
NASDAQ |
Nov 18, 16:00
3.695
0.00 (0.00%)
Pre-Market: 20:00
ARS Pharmaceuticals Gross Profit Margin (Quarterly) : 73.22% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 73.22% |
| June 30, 2026 | 61.83% |
| March 31, 2026 | 72.29% |
| December 31, 2025 | 78.09% |
| September 30, 2025 | 74.80% |
| June 30, 2025 | 68.29% |
| March 31, 2025 | 82.77% |
| December 31, 2024 | 98.82% |
| September 30, 2024 | 93.57% |
| June 30, 2024 | 96.40% |
| Date | Value |
|---|---|
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | -100.0% |
| March 31, 2023 | 0.00% |
| December 31, 2022 | 0.00% |
| September 30, 2022 | 96.30% |
| June 30, 2022 | -105.2% |
| March 31, 2022 | 92.46% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -308.6% |
| Return on Assets | -67.11% |
| Return on Invested Capital | -119.9% |
| Profit Margin (Quarterly) | -94.37% |
| Operating Margin (Quarterly) | -90.62% |
| Return on Net Operating Assets | -307.9% |